Skip to main content

Currently Skimming:

Reflecting Back: Forum Activities in 2011
Pages 4-9

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 4...
... In March 2011, the Forum collaborated with the IOM's Forum on Medical and Public Health Preparedness for Catastrophic Events to conduct, at the request of FDA, a workshop that examined ways to advance regulatory science for MCM development and regulatory evaluation; identified scientific opportunities to improve, simplify, or speed MCM development; and identified tools and methods to improve the predictability and success rate of candidate MCMs. FORUM ACTIVITIES TIMELINE 2000–2004 2005 Clinical Research Roundtable, predecessor to the Drug Forum
From page 5...
... The workshop focused closely on the core compo nents of a robust discipline of regulatory science; deliberated on the key competencies for a regulatory science workforce; and examined needs and opportunities to promote training, career development, and collaborative approaches to sustain and nurture a workforce in innovative regulatory sci ence. The workshop was held at the request of Forum sponsor Burroughs Wellcome Fund (BWF)
From page 6...
... Discussions at the workshop included consideration of the structures and culture of health care systems and delivery organizations that fail to support or engage with the clinical trials enterprise; how academic medical centers can create successful community partnerships to improve public engagement in clinical trials; models, methods, and messages for communication and engagement with the public; and novel clinical trial designs (such as adaptive clinical trial designs) that minimize enrollment needs and address treatment assignment concerns of physicians and their patients.
From page 7...
... The workshop focused on core themes, including vision for a clinical trials enterprise in the health care system of 2020; clinical trials workforce devel opment; alignment of cultural and financial incentives; and infrastructure to support a transformed clinical trials enterprise. Developing Drugs for Rare and Neglected Diseases and Addressing Urgent Global Health Problems Facing the Reality of Multidrug-Resistant Tuberculosis: Challenges and Potential Solutions in India -- Workshop (April 2011)
From page 8...
... In April 2011, the Forum hosted the third workshop in its workshop series on MDR TB in New Delhi, India. The workshop was held in partnership with the Indian National Science Academy and the Indian Council of Medical Research, and took place at the Indian National Science Academy conference facility.
From page 9...
... , a collaboration between the Howard Hughes Medical Institute and the University of KwaZulu-Natal. In November 2011, in Moscow, Russia, the Forum partnered with the Russian Academy of Medical Sciences to hold an official release event, which was held in conjunction with a meeting hosted by the International Science and Technology Center addressing pediatric DR TB.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.